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Infrared and Raman screening of seized novel
psychoactive substances: a large scale study of
>200 samples†
L. E. Jones,a A. Stewart,a K. L. Peters,b M. McNaul,b S. J. Speers,c N. C. Fletcherd and
S. E. J. Bell*a
The potential of IR absorption and Raman spectroscopy for rapid identiﬁcation of novel psychoactive sub-
stances (NPS) has been tested using a set of 221 unsorted seized samples suspected of containing NPS.
Both IR and Raman spectra showed large variation between the diﬀerent sub-classiﬁcations of NPS and
smaller, but still distinguishable, diﬀerences between closely related compounds within the same class. In
initial tests, screening the samples using spectral searching against a limited reference library allowed only
41% of the samples to be fully identiﬁed. The limiting factor in the identiﬁcation was the large number of
active compounds in the seized samples for which no reference vibrational data were available in the
libraries rather than poor spectral quality. Therefore, when 33 of these compounds were independently
identiﬁed by NMR and mass spectrometry and their spectra used to extend the libraries, the percentage
of samples identiﬁed by IR and Raman screening alone increased to 76%, with only 7% of samples having
no identiﬁable constituents. This study, which is the largest of its type ever carried out, therefore demon-
strates that this approach of detecting non-matching samples and then identifying them using standard
analytical methods has considerable potential in NPS screening since it allows rapid identiﬁcation of the
constituents of the majority of street quality samples. Only one complete feedback cycle was carried out
in this study but there is clearly the potential to carry out continuous identiﬁcation/updating when this
system is used in operational settings.
Introduction
Novel Psychoactive Substances (NPS), often known in the
media as “legal highs”, are a widespread and growing issue for
police and forensic services. The number of substances
reported to the European Monitoring Centre for Drugs and
Drug Addiction (EMCDDA) has risen from 13 in 20081 to 101
in 2014.2 These substances can be marketed as “not for
human consumption” or “research chemicals”3 from internet
sellers or head shops and their composition is constantly
changing in order to circumvent drug legislation. As with
established drugs of abuse the negative health impacts associ-
ated with Novel Psychoactive Substances have brought them to
the attention of the wider forensic community as well as
public media. The number of fatalities in England and Wales
where NPS were included in the death certificate increased
from 29 in 2011 to 52 in 20124 and this figure is likely to rise
as more new and untested compounds become available. The
adverse health eﬀects of NPS provide an additional incentive
for developing rapid methods to identify NPS as a public
health protection issue as well as a challenge to the criminal
justice system.
The ever changing nature of this illicit drug population is
diﬃcult to address using the established analytical tools,
GC-MS and HPLC-MS, which are normally employed by foren-
sic laboratories for identification and quantification of drugs
of abuse.5,6 In part this is because the sample preparation
steps used for GC-MS and HPLC-MS make them unsuitable for
high throughput rapid screening although fast GC-MS has
shown some promise.7 In addition, these methods work best
when certified reference standards are available for compari-
son and for NPS such standards are often not available.
Here we have carried out a large study on a randomly
selected set of seized samples which were obtained under con-
ditions which mean they have the same composition and
†Electronic supplementary information (ESI) available: 1H NMR spectra of the
33 identified compounds. See DOI: 10.1039/c5an02326b
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diversity as the general population of NPS available at street
level. The main techniques used were attenuated total reflec-
tion infrared absorption (ATR-IR) and Raman spectroscopy,
since both these techniques are non-destructive, fast and in-
expensive whilst still giving data unique to each compound.8
Previous studies have shown that Raman spectroscopy is
useful for the identification and analysis of “traditional” drugs
of abuse, for example: ecstasy,9–14,17 amphetamines9,15,17 and
cocaine,9,16,17 as well as pharmaceutical drugs.18–21 More
recently small scale studies on Raman,22,23 and IR24,25 analysis
of NPS have been published.
The aim of this paper is to establish if a strategy of using
vibrational spectroscopy, supplemented by other identification
methods as required, can provide an eﬀective method of
meeting the challenges set by NPS in real operational con-
ditions. There are two separate problems: one is to increase
sample throughput by decreasing analysis times, the second is
how to make such a screening process work in an environment
where previously unknown compounds are expected to appear
frequently in the sample set. In the current study this will be
addressed using a two stage approach. In the first stage the
proportion of samples which can be identified using ATR-IR
and Raman spectroscopy, combined with spectral library
searching, will be determined. More importantly, the samples
for which there are no reference spectra in the libraries will
also be detected. As discussed above, it is inevitable that
libraries will be incomplete since new variants are appearing
much more quickly than the supply of certified standards. The
second stage will then involve identification and characteri-
sation of these unknown compounds using NMR and mass
spectrometry. ATR-IR and Raman spectra of these samples will
then be added into the spectral libraries and the screening
process repeated using the extended reference data. This
second screening step will give a better estimate of how
eﬀective the ATR-IR and Raman screening can be if the spec-
tral libraries are continuously updated with data for previously
unknown NPS as soon as they appear.
Experimental
IR spectra were recorded using a Bruker Alpha FT-IR spectro-
meter with ATR attachment operating in single bounce mode.
Spectra were recorded using 24 scans in the 400–4000 cm−1
range with a resolution of 4 cm−1. Raman data were acquired
with two systems; an Avalon Instruments RamanStation R2
equipped with a 785 nm diode laser (ca. 100 mW at sample).
The spectrometer recorded spectra over the range of
100–3200 cm−1 with sampling resolution 2 cm−1, using an
echelle spectrograph and an Andor Technology Ltd CCD
cooled to −50 °C. 10–20 mg of each sample was placed onto
aluminium foil covering a 24-well terraced plate and 4 spectra
acquired for 10 s each in a 2 mm square grid pattern. A Perkin
Elmer RamanMicro200, which uses a 300 mW (at source)
785 nm diode laser, 6 cm−1 resolution, was also utilised.
Microscope data were collected using a 20× objective, which
focuses the laser beam onto a 40 µm spot, at 40% laser power
for 10 s, unless otherwise stated. A small spatula full (<10 mg)
of each sample was deposited onto an aluminium covered
glass slide. Powders and crystalline solids were analysed
without preparation. Tablets were first analysed without prepa-
ration and then crushed with a mortar and pestle and/or their
outer coating removed with a sharp blade. Raw spectra from
all Raman and IR instruments were viewed and processed in
GRAMS/AI v7.02 software and spectral searching was carried
out in SpectralID, a sub-program of GRAMS. All samples were
provided by Forensic Science Northern Ireland (FSNI).
Proton NMR spectra were recorded on either a Bruker
AVX300 (300 MHz) or an AVX400 (400 MHz) spectrometer as
dilute solutions in deuterated chloroform (CDCl3) or deuter-
ated dimethylsulfoxide (DMSO-d6). Chemical shifts were refer-
enced to the residual protonated solvent (7.26 and 2.50 ppm,
respectively). Carbon NMR spectra were recorded on either
Bruker AVX300 (75 MHz) or AVX400 (100 MHz) instruments
and chemical shifts were referenced to residual protonated
solvent (77.0 ppm for CDCl3 and 39.5 ppm for DMSO-d
6).
When required, assignments for 1H and 13C NMR spectra were
aided by two-dimensional NMR spectroscopy (COSY, HSQC).
Mass spectra were recorded using a Waters GTC Premier Elec-
tron ionization (EI) time-of-flight spectrometer.
Results and discussion
A total of 221 samples were screened using IR and Raman
spectroscopy. These samples, which were provided by Forensic
Science Northern Ireland (FSNI), were obtained from un-
completed postal deliveries which on inspection by the carrier
were found to contain materials which were either labelled as
NPS or whose appearance suggested they were NPS. The only
samples excluded from this study were those of herbal mix-
tures. This is because herbal mixtures contain a very low con-
centration of active ingredient (cannabinoid)26,27 and therefore
screening of these materials will be the subject of a diﬀerent
study. For each of the 221 samples the IR spectrum was
recorded and four Raman spectra taken at diﬀerent
positions within the sample. In general, the IR spectra were
consistently high quality, whereas the quality of the Raman
spectra (in particular the background fluorescence level)
varied significantly between samples. However, since there
were several processing options available for the Raman
spectra the spectra of all samples were graded 1–4 according to
both the quality of the raw data they provided and the level of
processing that was required to make them suitable for spec-
tral searching. Representative examples of each grade are
shown in Fig. 1.
Table 1 shows the criteria for each of the 4 grades used. The
Raman spectra of more than 75% of samples were Grade 1 or
2 and so required little or no spectral processing. The Grade
assigned to each sample was found to be the same for both
Raman instruments used, since both used the same excitation
wavelength and the diﬀerence in resolution was too small to
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give any noticeable diﬀerence in the spectra. Typically, when
spectral quality fell to Grade 3 or 4 this was due to fluo-
rescence. Although the IR spectra did not suﬀer from fluo-
rescence problems, the presence of carbohydrates (e.g.
microcrystalline cellulose, D-mannitol etc.) masked the peaks
from the active ingredients as they all have a broad peak at
approximately 1000 cm−1. Both carbohydrate and fluorescence
interference were more commonly found for the tableted
samples than the powders, in part because in the tablets the
proportion of active drug is reduced by the excipient.
The compounds identified in the samples encompassed a
range of the diﬀerent sub-classifications of NPS, including,
but not limited to, stimulant-like drugs (cathinones, amphet-
amines), synthetic cannabinoids and hallucinogens (trypta-
mines). Fig. 2 shows the Raman spectra of a small selection of
the NPS studied. As would be expected, the spectra of the
diﬀerent drug types are very diﬀerent from each other. More-
over, it is also possible to distinguish between even closely
related compounds within each category. For example, mephe-
drone (4-methylmethcathinone, 4-MMC) and 4-ethylmethcathi-
none (4-MEC) diﬀer only by a single methyl group and
therefore their spectra (Fig. 3(a) and (b)) have many features in
common. However, their spectra also show distinguishable
characteristics for each compound; the Raman spectrum of
4-MMC displays a characteristic peak at 1167 cm−1 that is not
present in 4-MEC.
Since more than 75% of the samples gave good quality
(Grade 1 or 2) spectra and each drug has a unique Raman
spectrum it might be expected that at least 75% of the samples
could be identified using Raman spectroscopy. In fact this is
not the case for two reasons, firstly the Raman spectral library
did not contain the spectra of some of the new drug com-
pounds which were present in the seized sample set and sec-
ondly, some of the samples were clearly composed of a
mixture of compounds. The first problem was addressed by
first principles identification of unknown samples, which is
Fig. 1 Typical Raman spectra of (a) Grade 4 sample (b) Grade 3 sample
(c) Grade 2 sample (d) Grade 1. Spectra are vertically oﬀset for clarity.
Table 1 Criteria for the grading the quality of the Raman spectra
Grade Criteria
1 Spectra required no processing to give convincing matches
2 Spectra required simple baseline correction or spectral
subtraction for spectral matches
3 Spectra required more advanced techniques such as
averaging, smoothing etc. for spectral matches
4 No spectral information was available even after extensive
processing
Fig. 2 Raman spectra of (a) mephedrone, 4-MMC (b) 4-methyl-
ethcathinone, 4-MEC (c) methamphetamine (d) 5,6-MDAI (e) ethyl-
phenidate (f ) AM-2201 (g) N,N-dimethyltryptamine. Spectra are
vertically oﬀset for clarity.
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described in more detail below. For the second problem, the
first task was to identify which samples had mixed compo-
sition. This was achieved by recording four Raman spectra at
diﬀerent positions across the surface of each sample. A more
detailed analysis of the experimental and statistical basis for
selecting 4 spectra as being suﬃcient to identify mixtures in
these types of samples will be published separately28 but in
essence this was found to be the best compromise between
recording numerous spectra of each sample and misclassifying
mixtures as pure compounds.
Since the mixtures were typically heterogeneous each of the
spectra in a mixed sample contained diﬀerent contributions
from the components present which appeared as a variation of
the relative peak heights at diﬀerent points. An example of this
eﬀect is shown in Fig. 3, where there is clear variation in the
relative peak heights in the 1600–1700 cm−1 range. This vari-
ation between the 4 spectra allowed the spectra of individual
components to be extracted from the raw data. In the simplest
cases, spectra recorded at some positions by chance showed
only one of the components in the mixture. The spectra at
these positions could be searched against the library in the
normal way. In other cases, where no single point gave a pure
spectrum, the library was searched and once the best match
was found its spectrum was subtracted from the mixture, as
shown in Fig. 4. The residual was then searched again to ident-
ify the second component etc.
The results of the screening by both Raman and IR are
illustrated in Fig. 5(a) and (b), respectively. In these Figures the
samples were grouped into four classifications. These were:
single components that have been identified, mixtures that
have been fully identified, mixtures where only some of the
compounds present have been identified and samples where
no matches were found and are completely unknown.
It is clear that for this first pass a significant number of
samples (41%) could not be identified using Raman spectro-
scopy and 21% were only partly identified. The results were
similar for the IR data, although in this case the number of
completely unidentified samples was lower at 33%. This was
predominantly due to IR spectroscopy’s superior ability to
identify carbohydrate excipients, which meant that samples
with high concentrations of these excipients were classified as
being partially or fully identified mixtures rather than
unknowns. However, pure samples of known drugs were typi-
cally identified with high confidence by both methods.
Combining the results from both approaches does improve
the overall results which can be obtained, as shown in Fig. 6.
However, the improvement is not dramatic, primarily because
samples which were easy to identify with one technique were
also easy for the other and vice versa. There were some
examples where a sample which was unknown in one tech-
nique could be identified, or partially identified with the other
but in general the overall eﬀectiveness was similar to that of
Fig. 3 Raman spectra recorded at 4 diﬀerent positions in a mixed
sample showing point-to-point variation in relative signal intensities.
Spectra are vertically oﬀset for clarity.
Fig. 4 ATR-IR spectra of (a) a mixed seized sample, (b) MPA reference
spectrum, (c) seized sample minus MPA reference, (d) lidocaine refer-
ence and (e) the residual spectrum after subtraction of both MPA and
lidocaine. Spectra are vertically oﬀset for clarity.
Fig. 5 Pie charts showing the degree to which the composition of the
seized samples could be determined using the original spectral libraries
and (a) Raman spectroscopy (b) IR spectroscopy. The meaning of the 4
diﬀerent classiﬁcations is given in the text.
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the most eﬀective individual technique. However, this does
not imply that combining IR and Raman screening is not
useful, the fact that two independent methods both produce
the same result gives an increased confidence that the identifi-
cation is correct. This confidence is important in a forensic
context, even for a screening method.
Fig. 6 shows that even using the combined IR and Raman
screening method only 41% of samples could be fully identi-
fied and 30% of the samples could not be fully or even par-
tially identified. In some cases a sample may not have
matched a reference because it gave a poor quality spectrum.
However, since >75% of the samples gave good quality (Grade
1 or 2) Raman spectra and all gave good quality IR spectra
poor quality was not the major issue. In fact, the main reason
that samples which were single compounds with low back-
grounds, and therefore should have been easy to identify, were
not matched in the library search was that their reference
spectra were missing from the library. This is unsurprising,
the appearance of previously unknown NPS in seized samples
means that the set of NPS whose spectra are available in
libraries inevitably lag behind the population of drugs in circu-
lation. Within the current study we therefore included a pro-
cedure in which the samples which appeared to be single
compounds but did match any library reference spectra were
selected for characterisation using NMR and MS. When these
samples had been confidently identified their reference
spectra were then added to the Raman and IR libraries.
The primary method of characterising the structures was
1H NMR, along with 13C NMR and high resolution mass
spectrometry. In some cases 2D NMR (COSY, HSQC) was used
to allow all of the peaks to be assigned with confidence. The
majority of the samples were in packaging that was labelled
with a chemical structure and/or the common name of their
supposed active ingredient. Although this is clearly not a
reliable guide to the contents, it was found to be useful in
many cases, so the first step of analysis involved comparing
the proton spectrum to the literature spectrum of the named
component, if one was available. In the few cases where no lit-
erature data could be found or the sample did not match its
stated composition, the splitting patterns in the proton spec-
trum, as well as mass spectrometry fragmentation pattern, 13C
NMR and 2D NMR were used as required to elucidate the
structure.
33 structures were identified in this manner, the 1H-NMR
of three examples are shown in Fig. 7. Fig. 8 shows the struc-
tures of these 33 compounds, the corresponding 1H-NMR data
are given in the ESI.† The ESI† also lists the names of the NPS
which were initially available in the spectral library which
covered the more common variants such as mephedrone and
MDMA. Following identification, the IR and Raman spectra of
the 33 compounds were added to the spectral libraries as ‘non-
standard’ reference spectra.
When the combined IR and Raman screening process was
repeated using the extended spectral libraries the proportion
Fig. 6 Pie chart showing the degree to which the composition of the
seized samples could be determined using a combination of Raman and
IR spectroscopy and the original spectral libraries. The meaning of the 4
diﬀerent classiﬁcations is given in the text.
Fig. 7 1H-NMR Spectra of (a) 4-methylbenzylcathinone (b) AB-FUBINACA (c) 5-EAPB. Spectra are vertically oﬀset for clarity.
Paper Analyst
906 | Analyst, 2016, 141, 902–909 This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
8 
Ja
nu
ar
y 
20
16
. D
ow
nl
oa
de
d 
on
 0
9/
03
/2
01
6 
14
:4
5:
03
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Fig. 8 Names and chemical structures of the 33 compounds that were identiﬁed using NMR and mass spectrometry within the seized sample set.
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of samples identified increased significantly. The results of
this second screening process are shown in Fig. 9. Notably, the
proportion of samples which could be fully identified on the
basis of their IR and Raman spectra increased from 41% to
76%. Additionally, the proportion of samples where no com-
ponents could be identified fell from 30% to 7%. Although the
proportion of spectral hits is well below 100% it is still cer-
tainly high enough to mean that screening using this method
will have a very significant eﬀect on the average time required
to characterise incoming casework samples, since approxi-
mately three quarters of all samples can be identified from
spectra which are accumulated in less than one minute with
no sample preparation. Subsequent data manipulation and
library searching requires a few seconds for IR spectra and the
better quality (Grade 1 & 2) Raman data. Even the data proces-
sing required for Grade 3 Raman spectra takes less than one
minute. This rapid data acquisition and processing means that
IR and Raman screening can dramatically increase sample
throughput over chromatographic methods and also free up
instrument capacity to address the small proportion of more
challenging samples which require detailed examination.
Conclusions
This large study was suﬃciently comprehensive to allow the
potential of combined IR and Raman spectroscopy for screen-
ing suspected samples for NPS to be explored under realistic
conditions. In particular, the sample set contained unsorted
samples with street level composition, including compounds
whose spectra were not initially available in the spectral
libraries used in the screening process. Initial results appeared
unpromising since a large proportion of the samples could not
be identified in the first screening cycle. However, this was
principally due to the incomplete state of the libraries rather
than a problem with the spectroscopy. Independent identifi-
cation of the compounds which did not match using a combi-
nation of NMR and MS allowed the sample library to be
extended. With the extended library the screening approach
allowed a much larger proportion of samples (76%) to be
identified by IR/Raman screening alone.
This study therefore suggests that although simple IR/
Raman screening using fixed libraries will be problematic due
to missing compounds, the more structured approach investi-
gated here has significant potential. In this approach, the first
pass screening allows known materials to be rapidly identified,
while any non-matching samples are detected in the screening
process and then taken for first principles identification,
which then feeds back into the spectral libraries. In this study
only one complete feedback cycle was carried out but there is
clearly the potential in operational settings to carry out con-
tinuous identification/updating or implement a system of
updating at regular intervals. This will give a rapid screening
system in which the composition of the majority of samples
are rapidly determined in the first pass and which continu-
ously evolves to meet the challenges imposed by the frequent
appearance of previously unreported NPS.
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